B0BAB7 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeie6areyu7ox7gxpd3hukiwb34hln25gh33cucyylwepicpm54chli/metadata.json
IPFS of structure file: 
bafybeiedmwj4klees4wecktmdftqmlrewhktlogyt2vqeumdl3m3dygt24/AF-B0BAB7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x32Dd5B71E48E579114B6a52f6D2542974C43ED9C
First NFT owner address (bech32): 
genesis1xtw4ku0y3etez99k55hk6f2zjaxy8mvu369w9m
Current NFT ID #166539 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166539
Accession (UniProt):
B0BAB7
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
CHLAMYDIA TRACHOMATIS SEROVAR L2B (STRAIN UCH-1/PROCTITIS)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B0BAB7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B0BAB7|HEM1_CHLTB Glutamyl-tRNA reductase OS=Chlamydia trachomatis serovar L2b (strain UCH-1/proctitis) OX=471473 GN=hemA PE=3 SV=1 MVREGEERIGNRVLLGVIGVSYRETTLQQREQVLHILQQAQGSFRPEVFQEERDYVLLATCHRVELYSVAPAELFDSLAQEIKLLGVSPYFYRNQDCFAHLFCVAGGLDSLVLGETEIQGQVKRAYLQAAREQKLSFALHFLFQKALKEGKVFRAKGGAPYAAITIPILVDQELRRRQIDKKASLLFIGYSEINRSVAYHLRRQGFSCITFCSRQQLPTLSMRQVVREELCFQDPYRVVFLGSLELQYALPHSLWESIWDIPDRIVFDFAVPRALPSHTVFPHRYMDMDQISDWLREHRKEVNSAHLDSLREVAYRYWNSLNQRLERHDCVGANA